PCMA Applauds Passage of New Jersey Legislation
June 20, 2019
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on passage of prescription drug legislation in New Jersey....
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
PCMA Opposes the Lower Health Care Costs Act
June 19, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Lower Health...
PBMs Advocate on behalf of Consumers to Reduce Prescription Drug Costs
June 19, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate Special...
PCMA Statement on the Lower Health Care Costs Act
June 18, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate Health,...
PCMA: Pharmacy Benefit Managers Increase Rx Access and Affordability for New Yorkers
June 03, 2019
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the New York Senate Investigations and Government Operations...
PCMA Statement on the Draft HELP Legislative Health Care Costs Package
May 23, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on draft legislation introduced...
Pharmacy Benefit Managers Support Increased Transparency in Prescription Drug Supply Chain
May 20, 2019
(Washington, D.C.) — As the Energy and Commerce Subcommittee on Health examines ways to bring more transparency to prescription drug...
PCMA Statement on the Administration’s Medicare Part D Rule
May 16, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Administration’s final...
Independent Drugstore Lobby Agenda Increases Prescription Drug Costs in New York
May 14, 2019
(Washington, D.C.) – As independent drugstore lobbyists descend on Albany for their special interest lobby day, the Pharmaceutical Care Management Association...
PCMA: Pharmacy Benefit Managers are the Sole Check Against Drug Manufacturers’ Pricing Power
May 09, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Energy and...
PCMA Statement on Competition in the Prescription Drug Marketplace
May 07, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Senate Judiciary...
May 02, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Congressional Budget...